Chattopadhyay, C.; Bhattacharya, R.; Roszik, J.; Khan, F.S.; Wells, G.A.; Villanueva, H.; Qin, Y.; Bhattacharya, R.; Patel, S.P.; Grimm, E.A.
Targeting IRS-1/2 in Uveal Melanoma Inhibits In Vitro Cell Growth, Survival and Migration, and In Vivo Tumor Growth. Cancers 2022, 14, 6247.
https://doi.org/10.3390/cancers14246247
AMA Style
Chattopadhyay C, Bhattacharya R, Roszik J, Khan FS, Wells GA, Villanueva H, Qin Y, Bhattacharya R, Patel SP, Grimm EA.
Targeting IRS-1/2 in Uveal Melanoma Inhibits In Vitro Cell Growth, Survival and Migration, and In Vivo Tumor Growth. Cancers. 2022; 14(24):6247.
https://doi.org/10.3390/cancers14246247
Chicago/Turabian Style
Chattopadhyay, Chandrani, Rajat Bhattacharya, Jason Roszik, Fatima S. Khan, Gabrielle A. Wells, Hugo Villanueva, Yong Qin, Rishav Bhattacharya, Sapna P. Patel, and Elizabeth A. Grimm.
2022. "Targeting IRS-1/2 in Uveal Melanoma Inhibits In Vitro Cell Growth, Survival and Migration, and In Vivo Tumor Growth" Cancers 14, no. 24: 6247.
https://doi.org/10.3390/cancers14246247
APA Style
Chattopadhyay, C., Bhattacharya, R., Roszik, J., Khan, F. S., Wells, G. A., Villanueva, H., Qin, Y., Bhattacharya, R., Patel, S. P., & Grimm, E. A.
(2022). Targeting IRS-1/2 in Uveal Melanoma Inhibits In Vitro Cell Growth, Survival and Migration, and In Vivo Tumor Growth. Cancers, 14(24), 6247.
https://doi.org/10.3390/cancers14246247